MPH Health Care AG
XETRA:93M1
Relative Value
The Relative Value of one
93M1
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 23.1 EUR,
MPH Health Care AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
93M1 Competitors Multiples
MPH Health Care AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
MPH Health Care AG
XETRA:93M1
|
98.9m EUR | 1 905.6 | -0.9 | -80.5 | -77.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
958.2B USD | 14.7 | 46.3 | 31.3 | 33.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.6B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.7B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
246B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.8B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.4B USD | 2.5 | 17.4 | 7.3 | 9 |